2.08
전일 마감가:
$2.07
열려 있는:
$2.09
하루 거래량:
90,459
Relative Volume:
0.72
시가총액:
$208.85M
수익:
-
순이익/손실:
$-60.14M
주가수익비율:
-2.9316
EPS:
-0.7095
순현금흐름:
$-68.17M
1주 성능:
+0.00%
1개월 성능:
+10.64%
6개월 성능:
-21.51%
1년 성능:
-40.23%
Ac Immune Sa Stock (ACIU) Company Profile
ACIU을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
ACIU
Ac Immune Sa
|
2.08 | 209.25M | 0 | -60.14M | -68.17M | -0.7095 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Ac Immune Sa Stock (ACIU) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-05-31 | 개시 | BTIG Research | Buy |
2019-02-01 | 다운그레이드 | UBS | Buy → Neutral |
2019-01-04 | 개시 | UBS | Buy |
2018-04-05 | 개시 | H.C. Wainwright | Buy |
2018-03-23 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
2016-10-18 | 개시 | Credit Suisse | Outperform |
2016-10-18 | 개시 | Jefferies | Buy |
2016-10-18 | 개시 | Leerink Partners | Outperform |
모두보기
Ac Immune Sa 주식(ACIU)의 최신 뉴스
AC Immune SA Stock Analysis and ForecastRapid market gains - PrintWeekIndia
Is AC Immune SA a good long term investmentFree Stock Market Real-Time Monitoring - PrintWeekIndia
What analysts say about AC Immune SA stockFree Buy/Sell Signal Notifications - Autocar Professional
What drives AC Immune SA stock priceAccelerated earnings growth - jammulinksnews.com
AC Immune patent discloses new NLRP3 inflammasome inhibitors - BioWorld MedTech
How AC Immune SA stock performs during market volatilityRisk Managed Trading Strategy - Newser
Why AC Immune SA stock attracts strong analyst attentionBig Return Stock Tips - Newser
What makes AC Immune SA stock price move sharplyFree Access to Community - Newser
Encoding an entire mAb against TDP-43 into AAV to treat neurodegenerative diseases - BioWorld MedTech
AC Immune SA Announces Board Changes Ahead of June 2025 AGM - TipRanks
Handelsbanken Fonder AB Trims Stake in AC Immune SA (NASDAQ:ACIU) - Defense World
AC Immune SA Announces Executive Changes - MarketScreener
AC Immune SA Announces Leadership Changes in Development Team - TipRanks
AC Immune SA (NASDAQ:ACIU) Held Back By Insufficient Growth Even After Shares Climb 31% - simplywall.st
Millennium Management LLC Sells 47,100 Shares of AC Immune SA (NASDAQ:ACIU) - Defense World
Promising Renewable Energy Stocks To Watch Now – June 9th - Defense World
Squarepoint Ops LLC Invests $118,000 in AC Immune SA (NASDAQ:ACIU) - Defense World
June 2025 Penny Stocks With Promising Potential - simplywall.st
Jane Street Group LLC Buys Shares of 24,283 AC Immune SA (NASDAQ:ACIU) - Defense World
Two Sigma Advisers LP Acquires Shares of 13,410 AC Immune SA (NASDAQ:ACIU) - Defense World
Pre-market Movers: LIMN, KRON, HSDT, CBUS... - RTTNews
ACIUAC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update - mx.advfn.com
Northern Trust Corp Makes New Investment in AC Immune SA (NASDAQ:ACIU) - Defense World
Individual investors among AC Immune SA's (NASDAQ:ACIU) largest shareholders, saw gain in holdings value after stock jumped 11% last week - simplywall.st
TRIALS UPDATE: The Latest Alzheimer’s Drug Development News (Q1 2025) - Being Patient
Dimensional Fund Advisors LP Has $355,000 Stock Holdings in AC Immune SA (NASDAQ:ACIU) - Defense World
AC Immune (NASDAQ:ACIU) Stock Rating Upgraded by StockNews.com - Defense World
AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update - ADVFN
AC Immune (ACIU) to Release Earnings on Monday - Defense World
AC Immune’s Promising Pipeline and Strong Financial Position Justify Buy Rating - TipRanks
AC Immune (NASDAQ:ACIU) Downgraded by StockNews.com to “Hold” - Defense World
Equities Analysts Issue Forecasts for AC Immune Q2 Earnings - Defense World
FY2027 EPS Estimates for AC Immune Cut by HC Wainwright - Defense World
HC Wainwright Lowers AC Immune (NASDAQ:ACIU) Price Target to $12.00 - Defense World
Planning For Perseverance - Life Science Leader
Ac Immune Sa (ACIU) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):